Hypothalamic-pituitary-adrenal function in patients with pituitary tumours.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000172:Acromegaly / Q000503:physiopathology*; D000238:Adenoma, Chromophobe / Q000503:physiopathology*; D000293:Adolescent; D000311:Adrenal Glands / Q000503:physiopathology*; D000324:Adrenocorticotropic Hormone; D000328:Adult; D002648:Child; D003397:Craniopharyngioma / Q000503:physiopathology*; D003907:Dexamethasone; D006801:Humans; D007003:Hypoglycemia; D007031:Hypothalamus / Q000503:physiopathology*; D007328:Insulin; D008239:Lysine; D008797:Metyrapone; D008875:Middle Aged; D010902:Pituitary Gland / Q000503:physiopathology*; D010911:Pituitary Neoplasms / Q000503:physiopathology*; D010912:Pituitary-Adrenal Function Tests; D011749:Pyrogens; D012658:Sella Turcica / Q000473:pathology; D014667:Vasopressins
D015065:17-Hydroxycorticosteroids; D007328:Insulin; D011749:Pyrogens; D014667:Vasopressins; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008239:Lysine; D008797:Metyrapone